Contribution of eukaryotic translation initiation factor 3B to the pathogenesis of hepatocellular carcinoma via targeting EGFR and ZAK.

被引:0
|
作者
Zheng, Jian-Feng
Jiang, Xiao-he
Chen, Yu
Cai, Li-li
Wang, Xiao-zhong
Guo, Wu-hua
Zhang, Ji-xiang
机构
[1] Nanchang Univ, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 2, Dept Gastroenterol, Nanchang, Jiangxi, Peoples R China
[3] Jiangxi Prov Key Lab Mol Med, Nanchang, Jiangxi, Peoples R China
关键词
D O I
10.1200/JCO.2016.34.15_suppl.e15587
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15587
引用
收藏
页数:2
相关论文
共 50 条
  • [41] MicroRNA-9 enhances sensitivity to cetuximab in epithelial phenotype hepatocellular carcinoma cells through regulation of the eukaryotic translation initiation factor 5A-2
    Xue, Fei
    Liang, Yuntian
    Li, Zhenrong
    Liu, Yanhui
    Zhang, Hongwei
    Wen, Yu
    Yan, Lei
    Tang, Qiang
    Xia, Erhui
    Zhang, Dongyi
    ONCOLOGY LETTERS, 2018, 15 (01) : 813 - 820
  • [42] Granzyme B inhibits translation of viral proteins and viral replication through proteolytic cleavage of the eukaryotic initiation factor 4 gamma 3
    Marcet-Palacios, Marcelo
    Duggan, Brenda
    Shostak, Irene
    Barry, Michele
    Wilkins, John
    Yanagiya, Akiko
    Sonenberg, Nahum
    Bleackley, R.
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [43] Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis
    Bai, Hai-Yan
    Liao, Yi-Ji
    Cai, Mu-Yan
    Ma, Ning-Fang
    Zhang, Qi
    Chen, Jie-Wei
    Zhang, Jia-Xing
    Wang, Feng-Wei
    Wang, Chen-Yuan
    Chen, Wen-Hui
    Jin, Xiao-Han
    Xu, Rui-Hua
    Guan, Xin-Yuan
    Xie, Dan
    STEM CELLS, 2018, 36 (02) : 180 - 191
  • [44] Eukaryotic initiation factor 3B is overexpressed and correlates with larger tumor size, advanced FIGO stage, and shorter overall survival in epithelial ovarian cancer patients
    Zhao, Nannan
    Guo, Yanjuan
    He, Yanfang
    Chen, Yan
    Xing, Jun
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (08)
  • [45] Eukaryotic initiation factor 3B downregulation suppresses cell proliferation, migration and invasion while it induces cell apoptosis by blocking the β-catenin pathway in endometrial cancer
    Min, Jie
    Chen, Hui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (09): : 3595 - 3603
  • [46] Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3
    Zhou, Ying
    Li, Yaoting
    Xu, Shihao
    Lu, Jing
    Zhu, Ziyi
    Chen, Shaoli
    Tan, Yuan
    He, Peng
    Xu, Jin
    Proud, Christopher G.
    Xie, Jianling
    Shen, Kaikai
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (05) : 1383 - 1395
  • [47] Phosphorylation of eukaryotic translation initiation factor 2Bε by glycogen synthase kinase-3β regulates β-adrenergic cardiac myocyte hypertrophy
    Hardt, SE
    Tomita, H
    Katus, HA
    Sadoshima, J
    CIRCULATION RESEARCH, 2004, 94 (07) : 926 - 935
  • [48] Global gene expression profiling reveals widespread yet distinctive translational responses to different eukaryotic translation initiation factor 2B-targeting stress pathways
    Smirnova, JB
    Selley, JN
    Sanchez-Cabo, F
    Carroll, K
    Eddy, AA
    McCarthy, JEG
    Hubbard, SJ
    Pavitt, GD
    Grant, CM
    Ashe, MP
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (21) : 9340 - 9349
  • [49] Establishment and Application of a High Throughput Screening System Targeting the Interaction between HCV Internal Ribosome Entry Site and Human Eukaryotic Translation Initiation Factor 3
    Zhu, Yuying
    Huang, Pei
    Yang, Na
    Liu, Rui
    Liu, Xueting
    Dai, Huanqin
    Zhang, Lixin
    Song, Fuhang
    Sun, Chaomin
    FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [50] RNA interference-mediated silencing of eukaryotic translation initiation factor 3, subunit B (EIF3B) gene expression inhibits proliferation of colon cancer cells
    Wang, Zheng
    Chen, Jinxian
    Sun, Jianhua
    Cui, Zhe
    Wu, Hui
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10